Virginia Retirement Systems’s Acceleron Pharma XLRN Stock Holding History

Virginia Retirement Systems’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,000	Closed	-$1.03M	–	1184
2021 Q3	$1.03M	Sell	6,000 -1,200	-17%	-$157K	0.01%	591
2021 Q2	$904K	Sell	7,200 -4,500	-38%	-$568K	0.01%	683
2021 Q1	$1.59M	Sell	11,700 -1,100	-9%	-$142K	0.02%	511
2020 Q4	$1.64M	Sell	12,800 -2,500	-16%	-$293K	0.02%	452
2020 Q3	$1.72M	Buy	15,300 +6,300	+70%	+$627K	0.02%	413
2020 Q2	$857K	Buy	9,000 +3,000	+50%	+$289K	0.01%	618
2020 Q1	$539K	Buy	+6,000	New	+$466K	0.01%	769

Virginia Retirement Systems's XLRN Position: Q4 2021 in Review

Virginia Retirement Systems sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 6,000 shares — an estimated $1.03M sold.

Virginia Retirement Systems first reported a position in XLRN in Q1 2020 and held it in 7 quarters. The position peaked at $1.72M in Q3 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Virginia Retirement Systems reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Virginia Retirement Systems sold 6,000 Acceleron Pharma shares in Q4 2021, an estimated $1.03M.
Virginia Retirement Systems first reported a position in Acceleron Pharma in Q1 2020 and held it in 7 quarters.
Virginia Retirement Systems's Acceleron Pharma position peaked at $1.72M in Q3 2020.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Virginia Retirement Systems's 13F filing for Q4 2021, filed 3 Feb 2022.